The Water Tower Hour

Send us a textIn this episode of Small Cap Spotlight x WTR Healthcare Happenings podcast, WTR's Tim Gerdeman, and Robert Sassoon welcomes back Nick Kadysh, Founding CEO and President of PharmAla Biotech (OTCQB: MDXXF). The discussion explores the evolving global regulatory environment for psychedelics—particularly MDMA—the ripple effects of the Lykos Therapeutics FDA Complete Response Letter (CRL) disclosures, and PharmAla's strategic approach to research, manufacturing, and commercialization of clinical-grade MDMA and next-generation analogues.

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Jeff Bonar, Chief Executive Officer of privately held CapCO2 Solutions, joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research to discuss: 1) how CapCO2 Solutions uses biogenic CO2 captured from ethanol biorefineries and intermittent wind power to produce low-cost, high volume green methanol; 2) what makes the process more efficient and cost-effective than traditional or competing methods; 3) how the technology also can support the production of SAF; 4) why and by how much green methanol demand is rising; 5) how the technology benefits the economics of ethanol plants, reduces emissions, and supports rural communities; and 5) how strategic partnerships and modular design enable rapid scaling and integration into existing ethanol facilities.

Send us a textIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman (Vice Chair, Co-Founder & CMO, Water Tower Research) and WTR's James Kisner speak with Giampaolo Marino, Senior Vice President of Strategy & Business Development at Energous (NASDAQ: WATT), about ambient-IoT wireless power networks, battery-free sensors, and enterprise adoption. Listen on Apple Podcasts, Spotify, or at watertowerresearch.com. 

Send us a textIn this episode of WTR Small-Cap Spotlight, Dr. David Sans, healthcare investment banker, former Novartis oncology researcher, and long-time biotech strategist, joins host Tim Gerdeman, Vice Chair, Co-Founder, and Chief Marketing Officer of Water Tower Research, for an in-depth discussion on the state of the biotech industry. Together, they explore why optimism is returning to the sector, which technologies and therapeutic categories are leading the rebound, and how investment and IPO trends are shaping the next phase of biotech growth.  Discover the bullish underpinnings of The Wall Street Journal article last week titled “Why Biotech's Rally Can Last This Time”.

Send us a textIn this episode of WTR Small-Cap Spotlight, Tony Scott, Chief Executive Officer, and Kimberly Pinson, Chief Financial Officer, of Intrusion Inc. (NASDAQ: INTZ) join co-hosts James Kisner, Managing Director of Technology Research at Water Tower Research, and Tim Gerdeman, Vice Chair, Co-Founder, and Chief Marketing Officer of Water Tower Research.The conversation dives into how Intrusion's Shield platform uses reputation-based threat intelligence and artificial intelligence to detect and block high-risk communications in real time. Scott and Pinson discuss the company's five consecutive quarters of sequential growth, the expansion of Shield Cloud into the AWS Marketplace (with Microsoft Azure coming later in 2025), and emerging opportunities in school safety, utilities, and critical infrastructure.They also touch on Intrusion's disciplined financial strategy, strong gross margins, and growing managed-service-provider channel—all of which position the company for sustained success in both government and commercial cybersecurity markets.

Send us a textIn this episode of the WTR Small-Cap Spotlight podcast, Sebastian Toke, CEO of GCL Holdings, joins Shawn Severson and James Kisner of Water Tower Research to discuss GCL's full-stack games & entertainment flywheel—connecting distribution (Epicsoft Asia, 2Game), publishing (4Divinity), and hardware/peripherals (Ban Leong Technologies) so data, marketing, and retail execution reinforce one another from IP origination to shelf.The conversation covers FY25 performance (+142% YoY revenue) and what management views as an inflection proving the ecosystem, GCL's role as global physical publisher for Black Myth: Wukong, momentum around Showa American Story, selective entry into mobile with Kingdom Under Fire: The Civil War (global rights except Singapore and Malaysia) targeted for end-2025, expectations for the next-gen console cycle, and how FY26 focuses on integrating software and hardware into a single operating flywheel.

Send us a textIn our latest Small-Cap Spotlight flashcast, Peter Gastreich, Managing Director at WTR breaks down his recent initiation of coverage report on Valero Energy Corp. (NYSE: VLO)

Send us a textIn this episode of the WTR Small-Cap Spotlight podcast, Steve Fife, President & CEO, and Carl Aure, CFO of LifeVantage (NASDAQ: LFVN), join Tim Gerdeman and Doug Lane of Water Tower Research to discuss the company's acquisition of LoveBiome, a fast-growing leader in gut health and direct sales.They explore how the deal strengthens LifeVantage's foundation in nutrigenomics, expands its presence in the rapidly growing $14B gut health market, and creates synergies across product lines like P84 and MindBody. Fife and Aure also discuss the integration of consultant networks, expected financial impact, and how LifeVantage is positioning for long-term, science-driven growth.

Send us a textIn this episode of the WTR Small-Cap Spotlight podcast, Bill Alessi, Founder & CEO and Chris Chumas, Chief Strategy Officer, of Alpha Modus Corp (NASDAQ: AMOD), joins Tim Gerdeman and James Kisner of Water Tower Research to discuss how the company is transforming in-store retail through its patented AI-driven technology ecosystem designed to enhance real-time shopper engagement and monetization.The conversation covers Alpha Modus' “super-aggregator” model for scaling smart retail networks, its expanding patent portfolio supporting long-term licensing revenue, and the upcoming 2026 rollout of financial-service kiosks for underbanked consumers. Alessi also highlights key partnerships with VSBLTY Groupe Technologies, Genmega, and Shelf Nine, advancing Alpha Modus' vision to be the backbone of AI-powered retail intelligence across computer vision, behavioral analytics, and retail media.

Send us a textWe welcome back Veru's CEO Mitch Steiner to our latest WTR Small-Cap Spotligh podcast. In this podcast, Steiner gives us his thoughts on the latest trends in the rapidly evolving GLP-1 market for weight loss, discusses the data from enobosarm's Phase 2b data, and explains  Veru's obesity drug development strategy in the wake of its recent positive interactions with the FDA.

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Inna Braverman, Chief Executive Officer of Eco Wave Power Global (NASDAQ ticker WAVE), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research to discuss: 1) WAVE's technology that generates stable, cost-efficient renewable energy from ocean and sea waves; 2) the company's global footprint with projects located across four continents including most recently in the US Port of Los Angeles; 3) competitive advantages like having extremely limited periods of intermittency; 4) the scalable attributes including the simplicity of the technology; 5) the importance of having "skin in the game" with management holding nearly 50% of company shares; and 6) key milestones for investors to focus on. 

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Bruce Fleming, Chief Executive Officer of Montana Renewables, an unrestricted subsidiary of Calumet (NASDAQ ticker CLMT), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research to discuss: 1) the company's role as the largest SAF producer in the Western Hemisphere; 2) key advantages including repurposing existing hardware for SAF production and proximity to carbon preference markets; 3) low cost expansion plans to reach up to 10x current SAF capacity by 2028; 4) the imminent squeeze in SAF markets and potential upward pressure on pricing; 5) the need for open feedstock policies and support of domestic agriculture and energy security; 6) top misconceptions about the SAF industry; and 7) other key topics.

Send us a textIn this WTR Small-Cap Spotlight Flashcast, host Tim Gerdeman, Vice Chair and Co-Founder of Water Tower Research, sits down with Shawn Severson, Founding Partner and CEO, to discuss the long-awaited rotation into small-cap stocks. The discussion explores the forces driving renewed investor attention to small caps, including monetary policy shifts, valuation disparities, and improving access to capital markets. Shawn also shares why small-cap investing today demands a stock-picker's mindset and what it will take to sustain this rally over the next year.

Send us a textTune in to the latest WTR Small-Cap Spotlight Flashcast! Join Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they discuss Nauticus Robotics. Nauticus develops autonomous underwater robots and innovative software, transforming offshore operations with safer, more efficient, and cost-saving solutions. Learn how KITT's: 2) flagship ToolKITT software and hardware like Aquanaut and Olympic Arm serve offshore industries such as energy, telecom, and defense; 2) technology reduces costs and CO2 emissions for its customers; and 3) high margin licensing fee strategy will accelerate scaling up of the business; and more!

Send us a textIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and WTR's Robert Sassoon speak with Marvin Slosman, CEO of InspireMD (NASDAQ: NSPR), to discuss how the company is transforming carotid artery disease treatment with its groundbreaking CGuard® Prime Carotid Stent System. The conversation covers FDA approval, clinical data, market adoption, competitive positioning, and InspireMD's long-term growth strategy.

Send us a textIn this exclusive symposium, hosted by Shawn Severson (Founding Partner & CEO) and Dmitry Silversteyn (Managing Director – Chemicals & Materials), industry leaders break down:Current market dynamics: global demand trends, supply bottlenecks, pricing pressures, and the role of top mining and processing regions.National security implications: why reducing dependence on China and other concentrated markets is critical for energy transition, defense, and technology sectors.Domestic infrastructure buildout: steps companies are taking to develop U.S. and allied processing capacity, including capital strategies, regulatory hurdles, workforce development, and government support.Actionable insights: what's needed to overcome challenges and accelerate domestic critical materials production for long-term resilience.This WTR Small-Cap Spotlight Symposium brings together executives from leading critical elements mining and processing companies to explore why building a secure, mine-to-materials supply chain is now a matter of national security—far beyond economics.Whether you're an investor, policymaker, or industry stakeholder, this episode delivers a front-row view into the future of critical elements and the companies shaping the global supply chain.

Send us a textIn this episode of WTR Small-Cap Spotlight, host Tim Gerdeman and WTR's James Kisner speak with James Gernetzke, CFO of Exodus Movement, Inc. (NYSE: EXOD) to explore how Exodus is building a next-generation platform for digital asset self-custody, multi-chain support, and stablecoin adoption. The conversation covers Exodus' high-growth business model, regulatory tailwinds, capital allocation strategy, and long-term vision for tokenized real-world assets. 

Send us a textIn this exclusive symposium, hosted by Shawn Severson (Founding Partner & CEO) and Dmitry Silversteyn (Managing Director – Chemicals & Materials), industry leaders break down:Current market dynamics: global demand trends, supply bottlenecks, pricing pressures, and the role of top mining and processing regions.National security implications: why reducing dependence on China and other concentrated markets is critical for energy transition, defense, and technology sectors.Domestic infrastructure buildout: steps companies are taking to develop U.S. and allied processing capacity, including capital strategies, regulatory hurdles, workforce development, and government support.Actionable insights: what's needed to overcome challenges and accelerate domestic critical materials production for long-term resilience.This WTR Small-Cap Spotlight Symposium brings together executives from leading critical elements mining and processing companies to explore why building a secure, mine-to-materials supply chain is now a matter of national security—far beyond economics.Whether you're an investor, policymaker, or industry stakeholder, this episode delivers a front-row view into the future of critical elements and the companies shaping the global supply chain.

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Peter Gastreich, Senior Energy Transition and Sustainable Investing analyst at Water Tower Research joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, to discuss: 1) implications from Southwest Airlines divesting its SAF venture; 2) investor sentiment toward SAF; 3) SAF's unique role in both energy and agriculture; 4) the critical role of SAF in meeting jet fuel demand and absorbing buoyant US crop yields; 5) questions investors should ask SAF project operators; and 6) companies advancing projects in the SAF supply chain (CLMT, DAR, GEVO, GPRE, HUSA, LODE, NESTE, REX, SAFX)

Send us a textIn this episode of the WTR Small-Cap Spotlight Podcast, host Tim Gerdeman, Vice Chair & Co-Founder of Water Tower Research, sits down with Ed Kovalik, Co-Founder, Chairman & CEO of Prairie Operating Company (NASDAQ: PROP), alongside WTR Energy Analyst Chris Degner.The discussion covers Prairie's transformative Bayswater acquisition, its growing asset base in the DJ Basin, and the company's strategy for production growth and cost efficiencies. Ed highlights environmental leadership in Colorado, the role of natural gas in powering AI-driven data centers, and innovative U-turn well drilling techniques.Whether you're an investor tracking small-cap energy companies or curious about the future of U.S. shale, this episode offers an in-depth look at Prairie's growth trajectory, operational strategy, and outlook for the energy sector.Tune in now on Apple Podcasts, Spotify, and WaterTowerResearch.com.

Send us a textIn this special edition of the WTR Small Cap Spotlight Flashcast, host Tim Gerdeman sits down with Doug Lane, WTR's Head of Consumer Products, to discuss the recent introduction of the WTR Consumer Stock Index with launch this summer of our Consumer Products Monthly industry report.  The discussion covers the thought process behind the companies chosen for the Index, how it is further broken down into 6 Sub-Indexes, and what are the indexes telling us about the state of Consumer investing so far in 2025.  The episode also covers the foreign exchange work that we include in the Monthly, as well as what broader trends we may expect to see for consumer stocks during the remainder of the year.

Send us a textIn this episode of the WTR Small-Cap Spotlight podcast, we are joined by Ludwig Enterprises (OTC: LUDG) Co-Founder and Chief Scientific Officer Marvin Hausman MD to talk about the company's innovative and proprietary mRNA genomic technology. Dr. Hausman discusses  how it revolutionizes  early detection of chronic inflammatory-driven diseases like cancer and advances the adoption of personalized medicine.

Send us a textIn this special episode of the WTR Small-Cap Spotlight Podcast, Jeff Karcher, Global Managing Director of the Texas Stock Exchange (TXSE), joins host Tim Gerdeman, Vice Chair & Co-Founder of Water Tower Research. With its highly anticipated launch planned for 2026, TXSE is positioning itself as a transformative force in U.S. capital markets. Backed by leading investors including BlackRock, Citadel, and Charles Schwab, the exchange plans to challenge incumbents like NYSE and NASDAQ by offering a fully electronic, pro-business, Dallas-based marketplace.Jeff shares insights into TXSE's launch timeline, listing requirements, competitive advantages, and how Texas's rising profile in finance and technology creates a unique backdrop for this ambitious project.

Send us a textIn this episode of WTR Small Cap Spotlight, host Tim Gerdeman, Vice Chair, Co-Founder and Chief Marketing Office of Water Tower Research is joined with Alex Verge, President & CEO of Journey Energy and Managing Director in Energy, Chris Degner for a discussion on Journey's growth investments in the in the Duvernay Shale. The conversation covers the economics of recent wells brought online, the depth of inventory for growth, underpinned with a stable, free cash flow generating production base and recent developments in the Canadian energy sector 

Send us a textIn this episode of WTR Small-Cap Spotlight, host Shawn Severson, CEO and Co-Founder of Water Tower Research, is joined by Herbalife CFO John DeSimone and WTR's Head of Consumer Products Equity Research Doug Lane for an in-depth discussion on Herbalife's improving business trends, strategic product and technology launches, and capital allocation priorities. The conversation covers leadership changes, sales force momentum, the launch of the Pro2col App, new health supplements, and the company's disciplined approach to debt reduction and growth investment. 

Send us a textCEO Brent Lucas of Envoy Medical (NASDAQ: COCH), an innovative hearing health technology company and sole US-domiciled cochlear implant company  joins the WTR Small-Cap Spotlight podcast to talk about hearing loss, the third most chronic physical condition prevalent in the US, and how  Envoy's innovative device technology can disrupt the hearing solutions market that has long lacked transformative advancements.  Lucas discusses Envoy's two fully implantable hearing solution products, one in the market (Esteem), the only FDA approved middle ear implant for moderate to severe hearing loss, and the other (Acclaim),  a cochlear implant targeting severe to profound hearing loss which is currently in the advanced stages of clinical development (Acclaim), the competitive landscape and the commercial opportunities. 

Send us a textThe passage of the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act, signed into law on July 18, 2025, represents a landmark moment for cryptocurrency regulation in the United States. Hear from leaders in crypto like Galaxy Digital and BTCS, and miners like Greenidge, BitFuFu, and Soluna on the near term and long term impacts of the US legislation.

Send us a textIn this special Flashcast episode of the WTR Small-Cap Spotlight, host Tim Gerdeman sits down with Dr. John Roy to explore the explosive trend of companies raising significant capital specifically to invest in cryptocurrency—a hot topic recently featured in the Wall Street Journal. They dive into the staggering scale of this trend, with nearly 100 companies announcing plans to raise over $43 billion for crypto purchases since June alone. John explains how the GENIUS Act has paved the way for greater corporate crypto adoption, especially around stablecoins, and outlines potential risks, including crypto's inherent volatility. The discussion highlights key players such as Capital Group and Galaxy Digital, who are leading this bold move into the crypto space.Tune in for expert insights into what's fueling this surge—and whether it's sustainable. 

Send us a textIn this episode of our WTR Small Cap Spotlight, we sat down with LifeVantage (NASDAQ: LFVN ) CEO Steve Fife and CMO Julie Boyster to drill down on the science of nutrigenomics, which is the study of how nutrients impact our genes, and how LifeVantage's proprietary formulations of naturally found ingredients work together to activate genes and help improve overall health and wellbeing.  Recent clinical studies further demonstrate the efficacy of the company's new patent-pending MindBody GLP-1 System, and the company discusses additional synergistic benefits from combining MindBody with the company's flagship Nrf2 Synergizer.   

Send us a textIn this special edition of the WTR Small-Cap Spotlight Flashcast, host Tim Gerdeman sits down with Chris Degner, Managing Director in Water Tower Research's Energy Practice, to explore major shifts in the oil and natural gas markets. The discussion covers rising OPEC production, evolving global supply structures, and a deep dive into LNG market trends—including emerging export projects in the U.S. and Australia. The episode also spotlights Tamboran Resources, a small-cap company with high-potential natural gas assets in Australia. Tune in for expert insights on where the energy markets are headed and what it means for small-cap investors. 

Send us a textIn this 2nd episode or our two-part WTR Symposium Series podcast, "NEXT-GEN VEHICLES: Investing in Small Drones and Unmanned Vehicles", senior management of Arrive AI (ARAI), Nauticus Robotics (KITT), Ocean Power Technologies (OPTT), and Palladyne AI (PDYN) join the Water Tower Research team including Founding Partner and CEO, Shawn Severson, Managing Director - Energy Transition and Sustainable Investing, Peter Gastreich, and Managing Director - Technology, Dr. John Roy. These companies are high-growth and with innovative unmanned vehicle solutions focused on improving efficiency and safety for industries as diverse as offshore oil & gas, subsea mining, offshore wind energy, pipelines, defense, surface logistics, and CO2 sequestration.

Send us a textIn our latest WTR-Small-Cap Spotlight podcast, we were joined by Jack Lu,  Director of corporate Development at Ainos (NASDAQ: AIMD) to discuss the company's pioneering smell digitization AI technology platform, AI Nose; diversification of the platform's penetration across multiple verticals through strategic partnerships;  commercialization opportunities and expansion goals.

Send us a textIn this episode of WTR Small-Cap x Healthcare Spotlight crossover episode, we are joined by Lisata Therapeutics' (NASDAQ: LSTA) CEO David Mazzo, PhD and Chief Medical Officer Kristen Buck, MD to talk about, Certepetide, the company's novel solid tumor targeting and penetration technology with tumor microenvironment modifying properties.  We also dive into the recently reported positive preliminary results from Lisata's lead program (Ascend), a Phase 2b study investigating Certepetide for metastatic pancreatic ductal adenocarcinoma (the most common and aggressive form of pancreatic cancer), Lisata's partnerships, and upcoming milestones.  

Send us a textIn this two-part WTR Symposium Series podcast, "NEXT-GEN VEHICLES: Investing in Small Drones and Unmanned Vehicles", management of Micropolis Holding Company (MCRP), Ondas Holdings Inc. (ONDS), SES AI Corp, (SES) and Unusual Machines, Inc. (UMAC) join the Water Tower Research team including Founding Partner and CEO, Shawn Severson and Managing Director - Technology, Dr. John Roy. Drones are everywhere and stocks are moving up. Hear what 4 CEOs in the drone industry are saying about investing, consolidation, and the need for standards. Stay tuned next week for part-two with WTR's Peter Gastreich!

Send us a textIn our latest WTR Small-Cap Spotlight x Healthcare Crossover, Cybin CEO Doug Drysdale joins Water Tower Research's Tim Gerdeman and Senior Analyst Robert Sassoon to discuss the company's non-traditional financing strategy as it continues to advance its development pipeline. Drysdale also probes into data that highlight advantages that distinguish Cybin's lead program CYB003 from other aspiring late-stage novel therapies in the depression treatment landscape  Cybin (NYSE: CYBN) is a late-stage clinical development company focused on developing novel psychedelic-based neuropsychiatric compounds. Its two lead candidates, targeting two of the most pervasive mental health disorders, are psilocin-based CYB003 for Major Depressive Disorder (MDD), currently being dosed in a Phase 3 program, and DMT-based CYB004 for General Anxiety Disorder (GAD) which is wrapping up a Phase 2 study.  

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Nir Brenmiller, Chief Operating Officer, Co-Founder and Director at Brenmiller Energy (NASDAQ ticker BNRG), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research to discuss: 1) the company's innovative heat storage technology that bridges the intermittency of renewable energy generation and provides clean energy in the form of steam to industrial and other customers; 2) the multi-trillion dollar market opportunity for decarbonization of heat and electrification of heat; 3) what makes the technology competitive and lower cost when compared to traditional boilers and natural gas; 4) the company's “heat as a service” business model targeting leading corporations looking to decarbonize; and 5) the first flagship operations starting by the end of this year plus a $500 million pipeline.

Send us a textIn Part 2 of our WTR Small-Cap Spotlight Executive Series with SurgePays (NASDAQ: SURG), we continue our conversation with President Derron Winfrey—shifting focus from the company's mobile virtual network enabler (MVNE) platform to its flagship mobile virtual network operator (MVNO) business, LinkUp Mobile. This episode explores how SurgePays is expanding affordable wireless access through its prepaid service model and what sets LinkUp apart in a competitive market.  

Send us a textIn this episode of the WTR Small-Cap | Biotech Spotlight Crossover, Water Tower Research's Tim Gerdeman is joined by Dr. Chris Witowski, CEO of Psilera, and WTR Senior Analyst Robert Sassoon for an insightful discussion on the company's pioneering work in neuroplastogen drug development and delivery technologies.Dr. Chris  Witowski, CEO and Co-Founder of Psilera, an early-stage biotech company focused on developing next-generation neuroplastegens for neurological and neuropsychiatric disorders, shares his thoughts and insights on the evolution of biomarkers in the neurosciences, the latest developments and trends in CNS-focused biomarkers and the potentially transformative impact they will have on the CNS treatment landscape.Tune in to learn more about Psilera's vision for the future of neurotherapeutics and how the company is working to transform the treatment landscape for CNS disorders.

Send us a textIn this WTR Symposium Series podcast, " CATCH THE WAVE: Investing in Water Treatment and Solutions ", management of Arq, Inc. (ARQ), California Water Service (CWT), National Energy Services Reunited (NESR), and Select Water Solutions (WTTR) join the Water Tower Research team including Shawn Severson, CEO and Co-founder, Jeff Robertson, Managing Director – Natural Resources, and Peter Gastreich, Senior Energy and Sustainable Investing Analyst to discuss growth strategies. The participating companies are delivering key water treatment technologies, water management solutions, and long-term infrastructure services for customers in energy, utilities, specialty materials and other industries.  

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Mihir Dange, CEO of XCF Global and Simon Oxley, CFO of XCF Global, joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainability Analyst at Water Tower Research to discuss: 1) XCF Global as the first publicly listed pure-play sustainable aviation fuel (SAF) producer in the US; 2) how decarbonizing the global aviation industry will lead to 100x demand growth for SAF; 3) status of the company's existing SAF plant in operation since Feb 2025 and XCF's large pipeline of new SAF projects; 4) the unique advantages of the feedstock and offtake agreements and partnership with Phillips66; and 5) the modular approach to expansion and focus on private capital financing rather than government loans.

Send us a textOn this week's episode of the WTR Small-Cap Spotlight, Roshan Pujari, Executive Chairman and CEO of Stardust Power joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainability Analyst at Water Tower Research to discuss: 1) the critical need for developing domestic lithium refining capacity in the US, a market which is dominated by imports; 2) plans to build one of the largest battery-grade lithium refineries in the US and strategic advantages of locating in Oklahoma; 3) progress on offtake agreements including 80-100% of phase 1 supply in a non-binding agreement with Sumitomo Corp; 4) Stardust Power's upstream integration strategy and the abundance of lithium reserves and brine assets linked to the oil and gas industry in the US; and 5) the company's financing and capital strategy.  

Send us a textEnlivex Therapeutics CEO Oren Hershkovitz, PhD joins us on another WTR Small-Cap x Biotech Spotlight crossover episode to talk about how the company's cell therapy, Allocetra, reprograms macrophages to treat inflammatory diseases. We dive into the recent Phase 1 data in knee osteoarthritis and what to expect from the randomized Phase 2 readout later this year, as well as the market opportunity. Listen to learn more about Enlivex Therapeutics and its off-the-shelf cell therapy platform. 

Send us a textOn this week's WTR Small-Cap Spotlight, we speak with Apimeds CEO Erik Emerson about the newly NYSE listed company and the development of Apitox, a purified honeybee venom, for knee osteoarthritis and multiple sclerosis. We discuss the therapeutic properties of bee venom and the clinical/regulatory plans to bring Apitox to the US market. Listen to learn more about Apimeds and its novel approach to treat inflammatory pain.

Send us a textOn our latest episode of Small-Cap Spotlight, WTR Co-Founder Tim Gerdeman, sits down with Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group, to break down the upcoming launch of OTCID and what it means for the future of small-cap investing. 

Send us a textOn this week's episode of Small-Cap Spotlight, WTR's Tim Gerdeman and Dmitry Silversteyn sit down with Howard Klein, Founder of RK Equity. With low metal prices all but precluding equity-based capital, miners and developers are looking to strategics and governments for funding to bridge the gap to the next upcycle.

Send us a textJindalee Lithium's CEO Ian Rodger discusses the company's McDermitt lithium resource in the context of developing a robust domestic critical metals ecosystem and provides an outline of milestones and deliverables stakeholders can look forward to as JLL  moves the project up the value chain. 

Send us a textSURG is excited about the opportunity to offer backend support, access to carrier network, and potentially, even outsourced customer care to virtual MVNOs that may have large subscriber bases, but don't have a direct relationship with a carrier. This Mobile Virtual Network Enabler (MVNE) market has opened up to SURG primarily because of its recent direct partnership with AT&T. 

Send us a textIn our latest Small-Cap Spotlight flashcast, Jeff Robertson, Managing Director of Natural Resources at WTR breaks down his recent initiation of coverage report on Journey Energy Inc.

Send us a textTune in to the latest Small-Cap Spotlight Flashcast! Join Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer at WTR, and Peter Gastreich, Senior Energy Transition and Sustainability Analyst, as they discuss Neste Corp. Neste produces renewable fuels on three continents and operates the world's largest renewable fuels platform. Learn how Neste's global footprint and feedstock sourcing serve as competitive advantages and how management are responding to the currently oversupplied renewable fuels markets, cutting costs and repositioning for structural long-term growth opportunities. Policy implications for the US and EU are also discussed. 

Send us a textWe are joined by Al Petrie, Senior Partner at Al Petrie Advisors, and Jeff Robertson, Managing Director of Natural Resources at Water Tower Research to discuss the upcoming Louisiana Energy Conference. The conference will be held at the Four Seasons Hotel in New Orleans, Louisiana from May 27- 29, 2025. Water Tower Research is pleased to be a sponsor of the event which has been held annually for 25 years. The conference will include approximately 36 presentations, panels, and discussions led by representatives from more than 80 organizations that will address key domestic and international oil, natural gas, renewable, and clean energy developments and topics. The agenda includes a wide array of topics covering the offshore and onshore domestic and international oil and gas industry, financing issues, energy transition, and the impact emerging technologies could have on the way companies operate. Attendance is directed to investment professionals, including buy- and sell-side analysts and portfolio managers, private equity, and wealth management executives and trust officers along with energy industry participants. The full agenda and registration information can be found at the following link, LEC 2025

Send us a textThis week we caught up with Hylton Karon, President and CEO of iFabric, to discuss the company's recent strong results and continued outlook for double-digit top line growth.  Founded by Hylton in 1985, the Canadian textile company eschews fashion for performance.  iFabric today offers textile products and technologies that cover a wide range of consumer markets such as athleisure, lifestyle, swimwear, healthcare, hospitality and military applications.  Hylton also explains that while the company today is known as Intelligent Fabrics, it will soon be known as Intelligent Technologies as it begins to offer solutions for hard surfaces as well.